ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Commodity Zero-Fee Gala

Avadel Pharmaceuticals plc (AVDL)

NASDAQ

$21.39

$--

(0.00%)

Avadel Pharmaceuticals plc (AVDL) Live Price Chart

Page last updated: 2026-02-12 13:01:00

Key Market Data

Market Cap	$2.10B
Open	$21.61
High	$23.57
Low	$1.03
Previous Close	$21.64
Price Change	--
Percentage Change	0.00%
Volume	200

Avadel Pharmaceuticals plc (AVDL) Stock Price Today

Avadel Pharmaceuticals plc (AVDL) is currently trading at $21.39 as of 2026-02-12 13:01:00, reflecting a 0.00% move ($-0.00) from the previous close.

In the short term, the stock has returned -51.16% over the past four weeks. Over the last 12 months, Avadel Pharmaceuticals plc has recorded a +140.07% price change, indicating a strong performance relative to the broader market.

Avadel Pharmaceuticals plc (AVDL) 7-Day Stock Price Changes

Over the past seven days, Avadel Pharmaceuticals plc has traded within a short-term range shaped by market sentiment in the PHARMACEUTICAL PREPARATIONS sector. During this period, the stock moved from its previous closing price of $21.60 to the latest recorded price of $21.39, reflecting an intraday change of 0.00%. Daily movements highlight shifts in trading volume (200), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, AVDL has delivered a -51.16% return over the past month and a +140.07% change in the last 12 months, indicating a strong trend relative to its broader sector peers.

How to Buy Avadel Pharmaceuticals plc (AVDL)

You can buy and trade AVDL on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for AVDL and Execute Your Trade

Open the trading page, enter AVDL in the search bar, select the amount of AVDL you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Avadel Pharmaceuticals plc (AVDL)?

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Avadel Pharmaceuticals plc Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	188
Sector	PHARMACEUTICAL PREPARATIONS
Company Website	https://www.avadel.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Avadel Pharmaceuticals plc?

The latest trading price for Avadel Pharmaceuticals plc (Common Stock) is $ 21.39, compared with a previous closing price of $ 21.64. That means the stock has moved 0.00% so far today. Intraday price updates and recent trading activity for AVDL can be tracked on the live chart and quote section on this page.

2.Is Avadel Pharmaceuticals plc stock going up or down?

Looking at recent performances, AVDL has returned -51.16% over the past month, +58.68% over the last six months and +140.07% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe strong price momentum for Avadel Pharmaceuticals plc stock, but keep in mind that past returns do not guarantee future results.

3.Where does AVDL currently sit relative to its 52-week high and low?

In the most recent 52-week period, Avadel Pharmaceuticals plc has traded between a low of $ 6.38 and a high of $ 23.57. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether AVDL is currently nearer the top or the bottom of its one-year trading band.

4.How is Avadel Pharmaceuticals plc classified by sector and industry?

Avadel Pharmaceuticals plc is classified in the PHARMACEUTICAL PREPARATIONS sector. In practice, this means Avadel Pharmaceuticals plc is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing AVDL’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the PHARMACEUTICAL PREPARATIONS sector could influence Avadel Pharmaceuticals plc’s performance.

5.Where is Avadel Pharmaceuticals plc listed and how large is it by market value?

Avadel Pharmaceuticals plc is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 2.10B, the company is classified as a Mid-cap stock. Market cap gives a quick sense of Avadel Pharmaceuticals plc's size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does AVDL's EPS tell investors about its profitability?

Trailing-twelve-month EPS of -- summarises how much profit Avadel Pharmaceuticals plc has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Avadel Pharmaceuticals plc's financial performance over time?

To follow Avadel Pharmaceuticals plc's financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how AVDL is performing and how the market is responding.

8.When is Avadel Pharmaceuticals plc expected to report earnings?

Avadel Pharmaceuticals plc's next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for AVDL, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Avadel Pharmaceuticals plc's earnings reports?

Avadel Pharmaceuticals plc's earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether AVDL is meeting, beating or missing expectations.

10.How can I stay informed about Avadel Pharmaceuticals plc's results and guidance?

You can stay up to date on Avadel Pharmaceuticals plc by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for AVDL on this page helps you see how new information is being reflected in the stock.

11.Does Avadel Pharmaceuticals plc pay a regular cash dividend to its shareholders?

Avadel Pharmaceuticals plc Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor AVDL's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for AVDL?

Based on the latest earnings data, AVDL has a dividend yield of 0 and a dividend payout ratio of --. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Avadel Pharmaceuticals plc is an attractive income stock. The dividend payout ratio measures what percentage of earnings Avadel Pharmaceuticals plc distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc is a publicly traded company in the PHARMACEUTICAL PREPARATIONS industry within the PHARMACEUTICAL PREPARATIONS sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is AVDL valued in terms of P/E ratio and EPS?

Avadel Pharmaceuticals plc currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of --. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Avadel Pharmaceuticals plc's earnings. Comparing AVDL's P/E and EPS to those of other PHARMACEUTICAL PREPARATIONS companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Avadel Pharmaceuticals plc

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Franklin Resources, Inc.

BEN

ChargePoint Holdings, Inc.

CHPT

Entergy Corporation

ETR

Goldman Sachs Group Inc.

Millrose Properties, Inc.

MRP

Top Gainers

Browse today's leading gainers in the US stock market

Haoxin Holdings Limited

HXHX

IPG Photonics Corporation

IPGP

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

AVDL-to-USD Calculator

Amount

AVDL

USD

1 AVDL = 21.39 USD